Docetaxel, Carboplatin and Fluoro-Uracil (TCF) Induction Therapy in Locally Advanced Head and Neck Squamous Cell Carcinoma (HNSCC) Patients with Contraindication for Cisplatin Based Combination (TPF)
Keyword(s):
2020 ◽
Vol 25
(5)
◽
pp. 768-774